High mobility group protein B1 (HMGB1) in Asthma: comparison of patients with chronic obstructive pulmonary disease and healthy controls.
about
The role of airway macrophages in apoptotic cell clearance following acute and chronic lung inflammationAssociation between HMGB1 and COPD: A Systematic ReviewRAGE: a new frontier in chronic airways diseaseSoluble receptor for advanced glycation end-products and progression of airway diseaseSmoking exposure induces human lung endothelial cell adaptation to apoptotic stress.Association between HMGB1 and asthma: a literature review.Changes of HMGB1 and sRAGE during the recovery of COPD exacerbationInnate immunity but not NLRP3 inflammasome activation correlates with severity of stable COPD.HMGB1 in health and disease.High mobility group box 1 induced human lung myofibroblasts differentiation and enhanced migration by activation of MMP-9.Physiologic concentrations of HMGB1 have no impact on cytokine-mediated eosinophil survival or chemotaxis in response to Eotaxin-2 (CCL24).Elevated HMGB1-related interleukin-6 is associated with dynamic responses of monocytes in patients with active pulmonary tuberculosis.High-mobility group box-1 induces vascular remodelling processes via c-Jun activationHMGB1 contributes to allergen-induced airway remodeling in a murine model of chronic asthma by modulating airway inflammation and activating lung fibroblastsHigh mobility group box 1: a novel mediator of Th2-type response-induced airway inflammation of acute allergic asthma.High mobility group box 1-induced epithelial mesenchymal transition in human airway epithelial cells.The role of High Mobility Group Box 1 chromosomal protein in the pathogenesis of chronic sinusitis and nasal polyposis.High-mobility group box 1 impairs airway epithelial barrier function through the activation of the RAGE/ERK pathway.Inflammation and immune response in COPD: where do we stand?A Systemic Inflammatory Endotype of Asthma With More Severe Disease Identified by Unbiased Clustering of the Serum Cytokine Profile.New insights into mechanisms controlling the NLRP3 inflammasome and its role in lung disease.Association of plasma sRAGE, but not esRAGE with lung function impairment in COPD.Functional interactors of three genome-wide association study genes are differentially expressed in severe chronic obstructive pulmonary disease lung tissue.DAMPs activating innate and adaptive immune responses in COPD.Asthma research in China: a five-year review.Circulating soluble receptor for advanced glycation end products (sRAGE) as a biomarker of emphysema and the RAGE axis in the lung.Genetic variance is associated with susceptibility for cigarette smoke-induced DAMP release in mice.Respiratory Syncytial Virus Infection Triggers Epithelial HMGB1 Release as a Damage-Associated Molecular Pattern Promoting a Monocytic Inflammatory Response.The epithelial barrier and immunoglobulin A system in allergy.Molecular pathogenesis in chronic obstructive pulmonary disease and therapeutic potential by targeting AMP-activated protein kinase.All the "RAGE" in lung disease: The receptor for advanced glycation endproducts (RAGE) is a major mediator of pulmonary inflammatory responses.HMGB1 is upregulated in the airways in asthma and potentiates airway smooth muscle contraction via TLR4.RAGE deficiency predisposes mice to virus-induced paucigranulocytic asthmaHistone 3.3 participates in a self-sustaining cascade of apoptosis that contributes to the progression of chronic obstructive pulmonary disease.Role of the inflammasome in chronic obstructive pulmonary disease (COPD).T-helper 2 cytokine-induced heat shock protein 70 secretion and its potential association with allergic rhinitis.The role of high-mobility group box-1 (HMGB1) in the pathogenesis of asthma.Alarmin HMGB1 induces systemic and brain inflammatory exacerbation in post-stroke infection rat model.High HMGB1 levels in sputum are related to pneumococcal bacteraemia but not to disease severity in community-acquired pneumonia
P2860
Q26767123-D6690126-08EB-4423-8CF9-730B551A3E2BQ26770022-E1EB4E69-4724-4F22-939A-295B5C59F946Q27025295-465BF7F3-0335-40FF-A864-8BF85AB0ED26Q33613288-ECBEC194-1185-4CBF-9858-2FE17CE440B3Q33756670-E342DAD6-EDDE-4351-9313-C01664F6A623Q33801198-B7C52451-F4FE-42DB-8DC2-470521841F00Q33814669-5886AB3A-2C17-4EBB-83D1-AF7323D25354Q34447539-7D5DD80A-979E-457B-B415-FBD20FC62271Q34622835-DF02CCD1-A1E9-4436-96F3-31BA1BF0D37BQ35096279-3833A2F5-D634-4324-88D6-42D98A466B5CQ35182609-6AEB180D-3697-403A-A39F-08B635B3753FQ35406168-1A4F1970-9EBB-43D7-80FE-2409E2D3A74EQ35571972-CE26BABE-F6B8-4FBB-86D9-7795999F1F9BQ35833616-8DB24070-66AD-4DD6-ACC6-AAFA3E98D524Q36254446-01DC5BA5-BC94-47F1-AFB4-DA440BDBEE4EQ36438398-53EF74EE-DD2D-45A3-A1D3-E9F43D2C33BBQ36555321-AE2F2368-536C-4176-86E7-3D5C480A22EEQ36791234-94C7475E-D45E-4330-B671-5883F9DEFFFFQ37057836-D6A6226D-DE03-4B2C-A5FA-8176DC0492C8Q37205073-0A4D5028-6C72-4036-AC52-FB8470672BBCQ37415404-23D1D709-AD9D-477C-B911-537BCE234583Q37620204-8F0EAAD3-8FB7-4B61-9278-3C8A4961DB37Q37695214-C74566C6-4489-4DE5-8617-3B6075A6D492Q38154796-E261587D-E356-4E15-A28C-2618E152F388Q38159723-A4197FBD-125B-4BA3-A248-C06BB5EFFF91Q38541559-AD961D32-6BDA-43EE-ACD4-6CABCEFA5BBFQ38700796-0D5BE4B9-2A80-47EC-B4C1-884B04FD729EQ38751350-CB72D3F9-CA74-41B9-86FA-B94A73F0157EQ38967737-703B7BB2-D2CA-4265-8077-6FF43D8ED421Q39119338-354A3494-A9C4-4EB0-A37F-60789970B518Q39246681-CB73E246-E3AC-478B-9FE3-66DCE4E7AF1AQ40308619-C8C4228A-A5D2-4B98-BC0C-206B7721D698Q40367443-ADB46E81-5398-499B-80DA-22FAE013AC20Q42909656-AD62EFFF-9C42-46B8-83C9-FF64C005E792Q47159702-5902007B-2E21-4633-A878-0A36FD0E18C0Q50971659-A246DE78-39CA-4940-AD62-C4AAE7E08FDEQ53364206-E898D7F0-6D56-43DF-95EA-2F7A9B489F52Q55223123-6C8A4F90-C6B3-4860-93B1-0285CCA84542Q58759782-6873C9C5-BD3A-4A47-8167-1E3E073CBA10
P2860
High mobility group protein B1 (HMGB1) in Asthma: comparison of patients with chronic obstructive pulmonary disease and healthy controls.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
High mobility group protein B1 ...... disease and healthy controls.
@ast
High mobility group protein B1 ...... disease and healthy controls.
@en
type
label
High mobility group protein B1 ...... disease and healthy controls.
@ast
High mobility group protein B1 ...... disease and healthy controls.
@en
prefLabel
High mobility group protein B1 ...... disease and healthy controls.
@ast
High mobility group protein B1 ...... disease and healthy controls.
@en
P2093
P2860
P1433
P1476
High mobility group protein B1 ...... disease and healthy controls.
@en
P2093
Changchun Hou
Haijin Zhao
Shaoxi Cai
Xiangbo Shen
Xiaoting Zhou
Zhenyu Liang
P2860
P2888
P304
P356
10.2119/MOLMED.2010.00173
P407
P577
2011-03-03T00:00:00Z
P5875
P6179
1068965315